Inflammatory myofibroblastic tumour

Basit Öğe Kaydı
dc.contributor.authorFirat, Ozgur
dc.contributor.authorOzturk, Safak
dc.contributor.authorAkalin, Taner
dc.contributor.authorCoker, Ahmet
dc.date.accessioned2019-10-27T20:51:22Z
dc.date.available2019-10-27T20:51:22Z
dc.date.issued2009
dc.departmentEge Üniversitesien_US
dc.description.abstractInflammatory myofibroblastic tumours (IMTs), previously accepted as a subtype of the group of tumours called inflammatory pseudotumours, are now recognized to comprise their own, discrete diagnosis. Since IMTs can arise from various anatomic locations,(1,2) they concern almost every subspecialty in surgical oncology. The management of these tumours can be challenging because there are no established medical treatment protocols, and tumours can be irresectable owing to their proximity to vital structures. We present the case of a patient whose IMT was removed after 2 trials of chemotherapy after 2 unsuccessful surgeries.en_US
dc.identifier.endpageE61en_US
dc.identifier.issn0008-428X
dc.identifier.issue3en_US
dc.identifier.pmid19503649en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpageE60en_US
dc.identifier.urihttps://hdl.handle.net/11454/43107
dc.identifier.volume52en_US
dc.identifier.wosWOS:000268198700027en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherCma-Canadian Medical Assocen_US
dc.relation.ispartofCanadian Journal of Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleInflammatory myofibroblastic tumouren_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu